Psychedelic Science 2017 Brings Experts and Visionaries Together
From April 19-24, Oakland, CA, will be the epicenter of the psychedelic movement as visionaries, creatives, and researchers join forces for Psychedelic Science, a conference held by MAPS (the Multidisciplinary Association of Psychedelic Studies). Conference passes are on sale now, and if you have any interest at all in the subject, you can be assured that this event is unmissable.
The last Psychedelic Science conference was four years ago in 2013, and it was a historic (and sold out) gathering. This year’s conference promises to be even richer. Its broad focus is “to share and discover new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.”
The conference will approach these topics over six days, including two days of pre- and post-conference workshops on Psychedelic Neuroscience, Holotropic Breathwork, and Immersive Visionary Art, among others. These workshops will be facilitated by leaders of each respective field, including Stanislav Grof, M.D., Bia Labate, Ph.D., Gabor Mate, M.D., and James Fadiman, Ph.D.
Three Tracks to Choose
The conference proper is organized into “tracks”—The Clinical Research Track, Interdisciplinary Research Track, and Plant Medicine Track—that participants can select based on their interests. Presenters include Rick Doblin, Ph.D., on The Future of Psychedelic Therapy, Anthony Bossis, Ph.D., on Psilocybin-Generated Mystical Experiences in Religious Leaders, and Jordi Riba, Ph.D., on neurogenesis and ayahuasca (Clinical Research Track); Elena Argento on the relationship between psychedelic use and reduced suicidality, Marc Aixalà, Ph.D., on the integration of difficult psychedelic experiences, and Paul Stamets on Mushroom Mycology (Interdisciplinary Research Track); and Brad Adams, Ph.D., on Ayahuasca, Psychiatric Distress, and the Meaning of Life, Shana Harris, Ph.D., on ibogaine treatment, Gabor Mate, M.D., on the use of plant medicines in “toxic culture,” Dennis McKenna, Ph.D., with new data on ayahuasca, and Sandor Iron Rope, with a presentation on indigenous perspectives on peyote (Plant Medicine Track).
For the full list of conference presenters and more information on presentation topics, click here.
A Visionary Weekend
The weekend will also include film screenings for conference attendees and Poster Sessions set up in the Marketplace, an area free and open to the public. The Marketplace will also be the site of the MAPS store, a Visionary Arts exhibit, and the Psymposia Stage (the spot for book signings and “late-night storytelling, ambient music, visionary art, tea, and community”).
MAPS is an internationally-renowned non-profit organization that has been a leader in the field of psychedelic research and education. MAPS is currently involved in studies on the therapeutic benefits of MDMA-assisted therapy and medical marijuana for PTSD. They recently completed the first double-blind, placebo-controlled study of the therapeutic use LSD in humans since the 1970s. They are also currently conducting and supporting studies on ibogaine-assisted therapy and ayahuasca.
Conference passes begin at $250 (student/military discount). A regular pass is $450. Workshops are an additional $150 each. Check out ticket options here.
The conference will take place at the Oakland Marriott City Center. Get your passes now, and stay tuned for more exclusive coverage of Psychedelic Science 2017 from Sensible Reason, who will be attending the conference in April.